Post-Market Surveillance: UDI Compliance for Class I Devices Moves Forward with New Deadline July 29, 2022 The FDA established the unique device identification (UDI) system to identify medical devices sold in the United States from manufacturing through patient use, which would ultimately modernize post-market surveillance. The final UDI Rule was published on September 24, 2013, with Class I and unclassified devices being the last implementation phase. In 2020 the FDA adjusted enforcement deadlines for some UDI requirements of Class I and unclassified devices, including UDI labeling, date formatting and Global Unique Device Identification Database (GUDID) submission requirements. This month, the FDA posted the final guidance: Unique Device Identification: Policy Regarding Compliance Dates for Class I and Unclassified Devices, Direct Marking, and Global Unique Device Identification Database Requirements for Certain Devices. Class I and unclassified devices will now have to comply with UDI by September 24, 2022. However, the FDA will not enforce GUDID submissions—except for implantable, life sustaining or life supporting devices—until December 8th, 2022. Here’s what we know. What Is the UDI Rule? The FDA’s drive behind the UDI regulation is to identify devices through distribution and use. UDI is a distinct alphanumeric/numeric code that will provide a single, globally harmonized system for traceability of a medical device. The UDI Rule requires device labels and packages, with some exceptions, to include a UDI. Devices that are required to have these labels must also be submitted to the repository of device safety information, GUDID, which is accessible to the public. This gives patients and healthcare providers visibility into medical device safety information. Extensions were granted to the original deadline to reduce the burden associated with the UDI Rule for finished devices. The Intention Behind UDI Compliance The UDI system will allow healthcare professionals to reduce medical records by quickly identifying devices and specific attributes related to their safe use. UDI will provide a standardized system for distributors, manufacturers and healthcare providers to manage recalls. It will also result in better reporting and a more effective method of analyzing adverse events and will help organizations identify counterfeiting, to provide a more secure, global supply chain. UDI’s effectiveness depends on high-quality data integrated into data sources such as the supply chain and electronic health records. This means UDI data must be accurate and complete. Enhancing Patient Safety and Efficiency in the Supply Chain The UDI system will enable healthcare providers to get the exact information needed to report adverse events accurately and manage recalls. The result is traceability throughout the supply chain for quicker recall and adverse event resolution and, ultimately, greater patient safety and higher efficiencies in the global supply chain. Healthcare professionals should be prepared to comply with the UDI Rule once it takes effect on September 24th. Not sure where to start? Get in touch with us to learn more. Resources About Complaints Handling: WEBINAR: Improving Postmarket Surveillance Across the Life Science Value Network – Comprehensive Postmarket Surveillance is more than receiving complaints and reporting to Regulatory Agencies. DATASHEET: Complaint Management Datasheet – Manage the entire complaint process with TrackWise Digital. Share via: Twitter LinkedIn Facebook Email
INFOGRAPHIC Automate and Visualize Batch Production | Elevate Efficiency and Quality TrackWise Experion Batch empowers Life Sciences manufacturers with advanced visualization, real-time data integration, and distributed batch control. Optimize productivity, ensure compliance, and maintain product quality with proactive decision-making and real-time alerts. Learn more
BROCHURE TrackWise Experion Batch DCS: Visualize Batch Production Like Never Before TrackWise Experion Batch combines Experion’s distributed control, batch automation, and unique visualization technology for a solution optimized for Pharmaceutical, Biopharmaceuticals, Medical Devices, and other batch applications. Learn more
EBOOK Three Strategies for Better Batch Visualization Discover how advanced batch visualization strategies can transform pharmaceutical manufacturing. Learn techniques to reduce cycle times, optimize efficiency, enhance troubleshooting, and minimize downtime through innovative process visualization solutions. Learn more
WHITE PAPER Leveraging Digitalization to Resolve Cell & Gene Therapy Manufacturing Challenges Life Science organizations are adopting modular facilities to speed up time-to-market and simplify product updates. Discover how modular automation and integrated platforms can optimize production, improve efficiency, and enhance compliance. Learn how to reduce integration time by 30-50% in this insightful whitepaper. Learn more
WHITE PAPER Increasing Manufacturing Flexibility with the Incremental Adoption of a Modular Platform Life Science organizations are adopting modular facilities to speed up time-to-market and simplify product updates. Discover how modular automation and integrated platforms can optimize production, improve efficiency, and enhance compliance. Learn how to reduce integration time by 30-50% in this insightful whitepaper. Learn more
WHITE PAPER Providing Enhanced Manufacturing Data to Contracting Companies: A CDMO Challenge and Opportunity Discover how the growing CMO and CDMO sector, projected to exceed $220 billion by 2023, can leverage data packs to enhance batch reports and critical insights. Learn about a platform-based approach to streamline data capture, meet client demands, and improve manufacturing efficiency. Learn more
WHITE PAPER Modular Automation: The Plug and Produce Opportunity for Life Sciences This whitepaper discusses the benefits of modular automation given the ongoing evolution to modular plants and what the industry dubs plug-and-produce processing. What standards should you be aware of as you make automation investments within the modular plant? How will modular technologies enable integration with component HMIs? What efficiency and cost impact can you expect to achieve? Learn more
WEBINAR Unifying Quality & Manufacturing – the Key to Optimizing Operational value Join industry experts Daniel Matlis, President & Founder of Axendia, Inc., and Steve McCarthy, VP of Industry & Business Development at Honeywell Life Sciences, as they discuss key trends and actionable strategies for unifying digital quality and manufacturing in the Life Sciences industry. Learn more
ON-DEMAND Revolutionizing Recall Management in Life Sciences Recalls are expensive. They can impact public health and brand’s reputation very quickly. Watch this recent on-demand to learn new ways to address Product Recall challenges. We will discuss new ways an organization can potentially mitigate recall risks as well as how to leverage new innovative solutions to drive a more efficient and effective recall management process. Learn more
BLOG 3 Types of Batch Technologies to Maximize Productivity and Profitability Productivity and profitability: Two words that are constantly at the forefront of every manufacturer’s mind. How can I make my operations, systems, and processes more productive and profitable? What new tools are available to help improve productivity and increase profitability? Learn more
BLOG The Evolution of MES: Why Honeywell’s New Manufacturing Excellence Platform Is a True Game-Changer for Pharmaceutical Manufacturing Manufacturing Excellence Platform takes the concept of a Pharma Manufacturing Execution System to a whole new level. Yes! It is that amazing Learn more
BLOG Honeywell’s Manufacturing Excellence Platform: Shaping the Future of Life Sciences Today Honeywell continues to push the boundaries with the recently launched Manufacturing Excellence Platform. As mentioned in our previous... Learn more
WHITE PAPER 99% Of Life Sciences Organizations Are Embracing AI. Are You? Life sciences organizations are enthusiastically embracing AI, but concerns over talent, skills, and data quality highlight the limitations of an in-house approach. Download this latest white paper to learn more. Learn more
EBOOK Accelerating Data-Driven Outcomes in Life Sciences Life sciences companies must adopt a strategic digital transformation approach, leveraging diverse data sources, data fabric, and dedicated business applications to remain competitive and agile. Download this Frost & Sullivan eBook to explore recent industry trends and how integrating data supports the progression toward Life Sciences 4.0 Learn more
ON-DEMAND TrackWise Electronic Logbooks With paper-based logging often leading to inefficiencies and compliance risks, it’s crucial to explore modern solutions. Watch our latest webcast, to see how the right e-Logbook can address these challenges and optimize your operations. Learn more